Position in NVS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$476,428
+$20,164 QoQ
Shares Held
3,040
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#909
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FLAGSHIP HARBOR ADVISORS, LLC holds $34,099,548 across 12 Drug Manufacturers - General names. NVS ranks #11 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,533 | $7,754,466 | |
| 2 | ABBV |
AbbVie Inc.
|
28,893 | $7,270,634 | |
| 3 | MRK |
Merck & Co., Inc.
|
50,083 | $6,435,665 | |
| 4 | LLY |
ELI LILLY & Co
|
4,913 | $5,892,800 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
29,492 | $1,699,329 | |
| 6 | PFE |
Pfizer Inc
|
70,067 | $1,687,213 | |
| 7 | AMGN |
Amgen Inc
|
2,672 | $967,584 | |
| 8 | AZN |
Astrazeneca PLC
|
2,895 | $548,949 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $476,428 | 3,040 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $456,264 | 2,987 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $367,837 | 2,668 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $365,355 | 2,849 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $338,101 | 2,794 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $350,716 | 3,146 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $373,865 | 3,842 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $411,771 | 3,580 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $388,366 | 3,648 | Shares | Sole | 2025-12-02 | |
| 2024-03-31 | $351,226 | 3,631 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $348,245 | 3,449 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $375,659 | 3,688 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $391,026 | 3,875 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $265,512 | 2,886 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $260,729 | 2,874 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $221,113 | 2,909 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $242,939 | 2,874 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $253,422 | 2,888 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $244,916 | 2,800 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $454,533 | 5,558 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $507,111 | 5,558 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $460,651 | 5,389 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $524,841 | 5,558 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $453,844 | 5,219 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $300,187 | 3,437 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $237,785 | 2,884 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||